Although there is currently no cure for NMO, research is ongoing.  There are currently three clinical trials underway for NMO:

  1. A B-cell depleting drug by MedImmune
  2. An Anti-IL6 blocking therapy (tocilizumab) by Chugai
  3. A complement-inhibitor (Eculizumab) by Alexion

 

Table of commonly used treatments (PDF)

Advertisements